These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 3133159)

  • 1. Serum lipid profile in women using levonorgestrel contraceptive implant, Norplant-2.
    Dash DS; Das S; Nanda U; Tripathy BB; Samal KC
    Contraception; 1988 Apr; 37(4):371-82. PubMed ID: 3133159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
    Loke DF; Ng CS; Samsioe G; Holck S; Ratnam SS
    Contraception; 1990 Nov; 42(5):535-54. PubMed ID: 2125546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD.
    Croxatto HB; Diaz S; Robertson DN; Pavez M
    Contraception; 1983 Mar; 27(3):281-8. PubMed ID: 6406139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Norplant implants on liver, lipid and carbohydrate metabolism.
    Singh K; Viegas OA; Loke DF; Ratnam SS
    Contraception; 1992 Feb; 45(2):141-53. PubMed ID: 1559336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Norplant contraceptive subdermal implants on serum lipids and lipoproteins.
    Otubu JA; Towobola OA; Aisien AO; Ogunkeye OO
    Contraception; 1993 Feb; 47(2):149-59. PubMed ID: 8449015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
    Anwar M; Soejono SK; Maruo T; Abdullah N
    Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
    Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN; Liew D; Ratnam SS
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the effects of Norplant implantable contraceptive on lipid, lipoprotein, and apolipoprotein metabolism in Singaporean women.
    Singh K; Ratnam SS
    Contraception; 1997 Aug; 56(2):77-83. PubMed ID: 9315415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
    Oyelola OO
    Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipids in Norplant implants users: a cross-sectional study.
    Affandi B; Suherman SK; Djajalelana ; Prihartono DJ; Lubis F; Samil RS
    Contraception; 1987 Oct; 36(4):429-34. PubMed ID: 3127112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipoproteins and fatty acid composition after "minipill".
    Sassolas A; Lagarde M; Guichardant M; Quincy C; Dechavanne M
    Contraception; 1983 Oct; 28(4):357-68. PubMed ID: 6421540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on serum lipids.
    Shaaban MM; Elwan SI; Abdalla SA; Darwish HA
    Contraception; 1984 Nov; 30(5):413-9. PubMed ID: 6440737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term and long-term effects of Norplant-2 on plasma lipoproteins and glucose tolerance.
    Bala Y; Dhall GI; Majumdar S
    Adv Contracept; 1991 Mar; 7(1):77-83. PubMed ID: 1908177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.